Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Stem Cell Research

Free Subscription Articles published in Blood Retrieve available abstracts of 301 articles: HTML format

Single Articles

April 2021
1. DUNBAR A, Levine RL
   "Interferon" with MPN hematopoietic stem cells.
   Blood. 2021;137:2129-2130.
   PubMed    
   
   
   
2. SVENDSEN AF, Yang D, Kim KM, Lazare SS, et al
   A comprehensive transcriptome signature of murine hematopoietic stem cell aging.
   Blood. 2021 Apr 19. pii: 475784. doi: 10.1182/blood.2020009729.
   PubMed     Abstract available
   
   
   
3. JUNG M, Smogorzewska A
   Endogenous formaldehyde destroys blood stem cells.
   Blood. 2021;137:1988-1990.
   PubMed    
   
   
   March 2021
4. CALVI LM
   FGF-23: a novel actor in stem cell mobilization.
   Blood. 2021;137:1434-1436.
   PubMed    
   
   
   
5. NAKAMURA-ISHIZU A, Chin D, Matsumura T, Tan DQ, et al
   Prolonged maintenance of hematopoietic stem cells that escape from Thrombopoietin deprivation.
   Blood. 2021 Mar 3. pii: 475410. doi: 10.1182/blood.2020005517.
   PubMed     Abstract available
   
   
   February 2021
6. RAO TN, Hansen N, Stetka J, Luque Paz D, et al
   JAK2-V617F and interferon-alpha induce megakaryocyte-biased stem cells characterized by decreased long-term functionality.
   Blood. 2021 Feb 24. pii: 475343. doi: 10.1182/blood.2020005563.
   PubMed     Abstract available
   
   
   
7. CHENG T, Hu L, Yin X, Zhang Y, et al
   Radiation-induced bystander effects impair transplanted human hematopoietic stem cells via oxidative DNA damage.
   Blood. 2021 Feb 24. pii: 475344. doi: 10.1182/blood.2020007362.
   PubMed     Abstract available
   
   
   
8. WANG N, Yin J, You N, Yang S, et al
   TWIST1 preserves hematopoietic stem cell function via CACNA1B/Ca2+/mitochondria axis.
   Blood. 2021 Feb 22. pii: 475282. doi: 10.1182/blood.2020007489.
   PubMed     Abstract available
   
   
   
9. JIA W, Poe JC, Su H, Anand S, et al
   BAFF Promotes Heightened BCR Responsiveness and Manifestations of Chronic GVHD after Allogeneic Stem Cell Transplantation.
   Blood. 2021 Feb 3. pii: 475149. doi: 10.1182/blood.2020008040.
   PubMed     Abstract available
   
   
   
10. ZHANG Y, Shen L, Dreissigacker K, Zhu H, et al
    Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease.
    Blood. 2021 Feb 2. pii: 475143. doi: 10.1182/blood.2020008720.
    PubMed     Abstract available
    
    
    January 2021
11. SONG Q, Wang X, Wu X, Qin H, et al
    Tolerogenic anti-IL-2 mAb prevents graft-versus-host disease while preserving strong graft-versus-leukemia activity.
    Blood. 2021 Jan 27. pii: 475053. doi: 10.1182/blood.2020006345.
    PubMed     Abstract available
    
    
    
12. FUCHS EJ, O'Donnell PV, Eapen M, Logan B, et al
    Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.
    Blood. 2021;137:420-428.
    PubMed     Abstract available
    
    
    
13. DING Y, Wang W, Ma D, Liang G, et al
    Smarca5-mediated epigenetic programming facilitates fetal HSPC development in vertebrates.
    Blood. 2021;137:190-202.
    PubMed     Abstract available
    
    
    
14. LE GOFF S, Boussaid I, Floquet C, Raimbault A, et al
    p53 activation during ribosome biogenesis regulates normal erythroid differentiation.
    Blood. 2021;137:89-102.
    PubMed     Abstract available
    
    
    December 2020
15. LAURENTI E
    Blood stem cells SELect quiescence.
    Blood. 2020;136:2967-2968.
    PubMed    
    
    
    
16. MYLLYMAKI M, Redd R, Reilly CR, Saber W, et al
    Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome.
    Blood. 2020;136:3070-3081.
    PubMed     Abstract available
    
    
    
17. TOLEDO MAS, Gatz M, Sontag S, Gleixner KV, et al
    Nintedanib Targets KIT D816V Neoplastic Cells Derived from Induced Pluripotent Stem cells of Systemic Mastocytosis.
    Blood. 2020 Dec 23. pii: 474778. doi: 10.1182/blood.2019004509.
    PubMed     Abstract available
    
    
    
18. 
    Garcia-Garcia A, Korn C, Garcia-Fernandez M, et al. Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes. Blood. 2019;133(3):224-236.
    Blood. 2020;136:2965.
    PubMed    
    
    
    
19. FIDANZA A, Stumpf PS, Ramachandran P, Tamagno S, et al
    Single-cell analyses and machine learning define hematopoietic progenitor and HSC-like cells derived from human PSCs.
    Blood. 2020;136:2893-2904.
    PubMed     Abstract available
    
    
    
20. LYNE AM, Laplane L, Perie L
    To portray clonal evolution in blood cancer, count your stem cells.
    Blood. 2020 Dec 11. pii: 474602. doi: 10.1182/blood.2020008407.
    PubMed     Abstract available
    
    
    
21. PUERTA-ALCALDE P, Champlin RE, Kontoyiannis DP
    How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.
    Blood. 2020;136:2741-2753.
    PubMed     Abstract available
    
    
    
22. STAUBER J, Greally J, Steidl U
    Preleukemic and Leukemic Evolution at the Stem Cell Level.
    Blood. 2020 Dec 4. pii: 474417. doi: 10.1182/blood.2019004397.
    PubMed     Abstract available
    
    
    
23. MENDEZ-FERRER S
    HSCs revive their niche after transplantation.
    Blood. 2020;136:2597-2598.
    PubMed    
    
    
    
24. GOLAN K, Singh AK, Kollet O, Bertagna M, et al
    Bone marrow regeneration requires mitochondrial transfer from donor Cx43-expressing hematopoietic progenitors to stroma.
    Blood. 2020;136:2607-2619.
    PubMed     Abstract available
    
    
    November 2020
25. HOPE KJ
    Making a bet on RET for hematopoietic stem cell expansion.
    Blood. 2020;136:2484-2486.
    PubMed    
    
    
    
26. STAAL FJT, Fibbe WE
    BETting on stem cell expansion.
    Blood. 2020;136:2364-2365.
    PubMed    
    
    
    
27. RAO S
    RUNX1 and inv(16) are frenemies in AML.
    Blood. 2020;136:2361-2362.
    PubMed    
    
    
    
28. HUA P, Hester J, Adigbli G, Li R, et al
    The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytes.
    Blood. 2020;136:2410-2415.
    PubMed     Abstract available
    
    
    
29. SURKA C, Jin L, Mbong N, Lu CC, et al
    CC-90009, a novel cereblon E3 ligase modulator targets acute myeloid leukemia blasts and leukemia stem cells.
    Blood. 2020 Nov 16. pii: 474181. doi: 10.1182/blood.2020008676.
    PubMed     Abstract available
    
    
    
30. GRECO R, Nitti R, Mancini N, Pasciuta R, et al
    Microbiome Markers are Early Predictors of Acute GvHD in Allogeneic Hematopoietic Stem Cell Transplant recipients.
    Blood. 2020 Nov 10. pii: 474128. doi: 10.1182/blood.2020007158.
    PubMed    
    
    
    
31. HANEKAMP D, Ngai LL, Janssen JJ, van de Loosdrecht AA, et al
    Early assessment of clofarabine effectiveness applying measurable residual disease, including AML stem cells.
    Blood. 2020 Nov 10. pii: 474126. doi: 10.1182/blood.2020007150.
    PubMed    
    
    
    
32. XIAO Y, van Halteren AGS, Lei X, Borst J, et al
    Bone marrow-derived myeloid progenitors as driver mutation carriers in high- and low-risk Langerhans cell histiocytosis.
    Blood. 2020;136:2188-2199.
    PubMed     Abstract available
    
    
    
33. SUBRAMANIAM A, Zemaitis K, Talkhoncheh MS, Yudovich D, et al
    Lysine-specific demethylase 1A restricts ex vivo propagation of human HSCs and is a target of UM171.
    Blood. 2020;136:2151-2161.
    PubMed     Abstract available
    
    
    
34. YOON IC, Bascou NA, Poe MD, Szabolcs P, et al
    Long-Term Neurodevelopmental Outcomes of Hematopoietic Stem Cell Transplantation for Late-Infantile Krabbe Disease.
    Blood. 2020 Nov 4. pii: 474073. doi: 10.1182/blood.2020005477.
    PubMed     Abstract available
    
    
    
35. LIU L, Inoki A, Fan K, Mao F, et al
    ER associated degradation preserves hematopoietic stem cell quiescence and self-renewal by restricting mTOR activity.
    Blood. 2020 Nov 4. pii: 474082. doi: 10.1182/blood.2020007975.
    PubMed     Abstract available
    
    
    
36. DE KONING C, Prockop S, Roessel IV, Kernan NA, et al
    CD4+ T-cell reconstitution predicts Survival Outcomes after acute Graft-versus-Host-Disease; a dual center validation.
    Blood. 2020 Nov 4. pii: 474078. doi: 10.1182/blood.2020007905.
    PubMed     Abstract available
    
    
    October 2020
37. YUAN CY, Zhou V, Sauber G, Stollenwerk TM, et al
    Signaling Through the Type 2 Cannabinoid Receptor Regulates the Severity of Acute and Chronic Graft versus Host Disease.
    Blood. 2020 Oct 7. pii: 464166. doi: 10.1182/blood.2020004871.
    PubMed     Abstract available
    
    
    
38. TSAI FD, Lindsley RC
    Clonal hematopoiesis in the inherited bone marrow failure syndromes.
    Blood. 2020;136:1615-1622.
    PubMed     Abstract available
    
    
    
39. TAKEDA R, Asada S, Park SJ, Yokoyama A, et al
    HHEX promotes myeloid transformation in cooperation with mutant ASXL1.
    Blood. 2020;136:1670-1684.
    PubMed     Abstract available
    
    
    September 2020
40. CURTIS LM, Ostojic A, Venzon D, Holtzman NG, et al
    A randomized phase-2 trial of pomalidomide in subjects failing prior therapy of chronic graft-versus-host disease.
    Blood. 2020 Sep 24. pii: 463981. doi: 10.1182/blood.2020006892.
    PubMed     Abstract available
    
    
    
41. CHAO NJ
    I have a gut feeling....
    Blood. 2020;136:1380.
    PubMed    
    
    
    
42. ZHEN T, Cao Y, Ren G, Zhao L, et al
    RUNX1 and CBFbeta-SMMHC transactivate target genes together in abnormal myeloid progenitors for leukemia development.
    Blood. 2020 Sep 14. pii: 463758. doi: 10.1182/blood.2020007747.
    PubMed     Abstract available
    
    
    
43. WILL B
    No keto for AML stem cells!
    Blood. 2020;136:1219-1221.
    PubMed    
    
    
    
44. KANAYAMA M, Izumi Y, Yamauchi Y, Kuroda S, et al
    CD86-based analysis enables observation of bona fide hematopoietic responses.
    Blood. 2020;136:1144-1154.
    PubMed     Abstract available
    
    
    
45. FENWARTH L, Thomas X, de Botton S, Duployez N, et al
    A Personalized Approach to Guide Allogeneic Stem Cell Transplantation in Younger Adults with Acute Myeloid Leukemia.
    Blood. 2020 Sep 1. pii: 463599. doi: 10.1182/blood.2020005524.
    PubMed     Abstract available
    
    
    August 2020
46. FUCHS EJ, O'Donnell PV, Eapen M, Logan BR, et al
    Double unrelated umbilical cord blood versus HLA-haploidentical bone marrow transplantation (BMT CTN 1101).
    Blood. 2020 Aug 31. pii: 463595. doi: 10.1182/blood.2020007535.
    PubMed     Abstract available
    
    
    
47. VILLEVAL JL, Vainchenker W
    Megakaryocytes tame erythropoiesis with TGFbeta1.
    Blood. 2020;136:1016-1017.
    PubMed    
    
    
    
48. WANG HY, Tzachanis D
    Extramedullary early T-cell precursor acute lymphoblastic lymphoma presenting as blast crisis of CML.
    Blood. 2020;136:1112.
    PubMed    
    
    
    
49. CATTO LFB, Borges G, Pinto AL, Cle DV, et al
    Somatic genetic rescue in hematopoietic cells in GATA2 deficiency.
    Blood. 2020;136:1002-1005.
    PubMed    
    
    
    
50. MYLLYMAKI M, Redd RA, Reilly CR, Saber W, et al
    Short Telomere Length Predicts Non-Relapse Mortality after Stem Cell Transplantation for Myelodysplastic Syndrome.
    Blood. 2020 Aug 17. pii: 463323. doi: 10.1182/blood.2020005397.
    PubMed     Abstract available
    
    
    
51. LACAUD G
    Decoding hematopoietic stem cells' birth.
    Blood. 2020;136:775-776.
    PubMed    
    
    
    
52. KOKKALIARIS K, Kunz L, Cabezas-Wallscheid N, Christodoulou C, et al
    Adult blood stem cell localization reflects the abundance of reported bone marrow niche cell types and their combinations.
    Blood. 2020 Aug 7. pii: 461765. doi: 10.1182/blood.2020006574.
    PubMed     Abstract available
    
    
    
53. LO RW, Li L, Pluthero FG, Leung R, et al
    The endoplasmic reticulum protein SEC22B interacts with NBEAL2 and is required for megakaryocyte alpha-granule biogenesis.
    Blood. 2020;136:715-725.
    PubMed     Abstract available
    
    
    
54. FAGNAN A, Bagger FO, Pique-Borras MR, Ignacimouttou C, et al
    Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.
    Blood. 2020;136:698-714.
    PubMed     Abstract available
    
    
    
55. MOHTY M, Holler E, Jagasia M, Jenq RR, et al
    Refractory acute graft-versus-host disease: a new working definition beyond corticosteroid refractoriness.
    Blood. 2020 Aug 5. pii: 461710. doi: 10.1182/blood.2020007336.
    PubMed     Abstract available
    
    
    
56. CHALLEN G, Goodell MA
    Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones.
    Blood. 2020 Aug 3. pii: 461691. doi: 10.1182/blood.2020006510.
    PubMed     Abstract available
    
    
    July 2020
57. CARLESSO N
    Targeting the bone marrow niche in hemoglobinopathies.
    Blood. 2020;136:529-531.
    PubMed    
    
    
    
58. FANG T, Zhang Y, Chang VY, Roos M, et al
    Epidermal growth factor receptor-dependent DNA repair promotes murine and human hematopoietic regeneration.
    Blood. 2020;136:441-454.
    PubMed     Abstract available
    
    
    
59. BLOUIN JM, Ged C, Lalanne M, Lamrissi-Garcia I, et al
    Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.
    Blood. 2020 Jul 17. pii: 461423. doi: 10.1182/blood.2020006037.
    PubMed     Abstract available
    
    
    
60. TAVEIRNE S, Wahlen S, Van Loocke W, Kiekens L, et al
    The transcription factor ETS1 is an important regulator of human NK cell development and terminal differentiation.
    Blood. 2020;136:288-298.
    PubMed     Abstract available
    
    
    
61. DEGREGORI J
    Aging, inflammation, and HSC.
    Blood. 2020;136:153-154.
    PubMed    
    
    
    
62. PRINS D, Green AR
    Mutant CALR functions: gains and losses.
    Blood. 2020;136:6-7.
    PubMed    
    
    
    
63. FRIEDRICH C, Barreau S
    A splenic lymphoma/leukemia with a spontaneous blast decrease without treatment.
    Blood. 2020;136:148.
    PubMed    
    
    
    June 2020
64. GREY W, Chauhan R, Piganeau M, Huerga Encabo H, et al
    Activation of the receptor tyrosine kinase, RET, improves long-term hematopoietic stem cell outgrowth and potency.
    Blood. 2020 Jun 26. pii: 461200. doi: 10.1182/blood.2020006302.
    PubMed     Abstract available
    
    
    
65. MATSUMURA T, Nakamura-Ishizu A, Muddineni SSNA, Tan DQ, et al
    Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia.
    Blood. 2020 Jun 23. pii: 461100. doi: 10.1182/blood.2019004292.
    PubMed     Abstract available
    
    
    
66. RAFFEL S, Klimmeck D, Falcone M, Demir A, et al
    Quantitative proteomics reveals specific metabolic features of Acute Myeloid Leukemia stem cells.
    Blood. 2020 Jun 18. pii: 461031. doi: 10.1182/blood.2019003654.
    PubMed     Abstract available
    
    
    
67. O'CONNELL RM, Rao DS
    Microsized inflammaging protects stem cells.
    Blood. 2020;135:2204-2205.
    PubMed    
    
    
    
68. GRANTS JM, Wegrzyn J, Hui T, O'Neill K, et al
    Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice.
    Blood. 2020;135:2235-2251.
    PubMed     Abstract available
    
    
    
69. MA WB, Wang XH, Li CY, Tian HH, et al
    GPS2 promotes erythroid differentiation by control of the stability of EKLF protein.
    Blood. 2020;135:2302-2315.
    PubMed     Abstract available
    
    
    
70. CHEN BY, Song J, Hu CL, Chen SB, et al
    SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
    Blood. 2020;135:2271-2285.
    PubMed     Abstract available
    
    
    
71. DI GIANDOMENICO S, Kermani P, Molle N, Yabut MM, et al
    Megakaryocyte TGFbeta1 Partitions Erythropoiesis into Immature Progenitor/Stem Cells and Maturing Precursors.
    Blood. 2020 Jun 16. pii: 460972. doi: 10.1182/blood.2019003276.
    PubMed     Abstract available
    
    
    
72. NORONA J, Apostolova P, Schmidt D, Ihlemann R, et al
    Glucagon like peptide-2 for Intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans.
    Blood. 2020 Jun 15. pii: 460963. doi: 10.1182/blood.2020005957.
    PubMed     Abstract available
    
    
    
73. NUMATA A, Kwok HS, Zhou QL, Li J, et al
    Lysine acetyltransferase Tip60 is required for hematopoietic stem cell maintenance.
    Blood. 2020 Jun 15. pii: 460960. doi: 10.1182/blood.2019001279.
    PubMed     Abstract available
    
    
    
74. TOUBAI T, Magenau JM
    Immunopathology and Biology Based Treatment of Steroid Refractory Graft-versus-Host Disease.
    Blood. 2020 Jun 11. pii: 460896. doi: 10.1182/blood.2019000953.
    PubMed     Abstract available
    
    
    
75. RAFEI H, Jenq RR
    Microbiome-intestinal crosstalk during acute graft-versus-host disease (GVHD).
    Blood. 2020 Jun 11. pii: 460893. doi: 10.1182/blood.2019000950.
    PubMed     Abstract available
    
    
    
76. HILL GR, Koyama M
    Cytokines and Co-stimulation in Acute Graft-versus-Host Disease.
    Blood. 2020 Jun 11. pii: 460895. doi: 10.1182/blood.2019000952.
    PubMed     Abstract available
    
    
    
77. VOERMANS C, Hazenberg MD
    Cellular therapies for graft versus host disease: a tale of tissue repair and tolerance.
    Blood. 2020 Jun 11. pii: 460894. doi: 10.1182/blood.2019000951.
    PubMed     Abstract available
    
    
    
78. STREMENOVA SPEGAROVA J, Lawless D, Mohamad SMB, Engelhardt KR, et al
    Germline TET2 Loss-Of-Function Causes Childhood Immunodeficiency And Lymphoma.
    Blood. 2020 Jun 9. pii: 460739. doi: 10.1182/blood.2020005844.
    PubMed     Abstract available
    
    
    
79. KEENAN CR, Iannarella N, Naselli G, Bediaga NG, et al
    Extreme disruption of heterochromatin is required for accelerated hematopoietic aging.
    Blood. 2020;135:2049-2058.
    PubMed     Abstract available
    
    
    
80. SUNG AD, R Nichols K, Chao NJ
    House Calls for Stem Cell Transplants During the COVID-19 Pandemic.
    Blood. 2020 Jun 2. pii: 460658. doi: 10.1182/blood.2020006573.
    PubMed    
    
    
    
81. ALTHOFF M, Nayak R, Hegde S, Wellendorf A, et al
    Yap1-Scribble polarization is required for hematopoietic stem cell division and fate.
    Blood. 2020 Jun 1. pii: 460601. doi: 10.1182/blood.2019004113.
    PubMed     Abstract available
    
    
    May 2020
82. YVERNOGEAU L, Klaus A, Maas J, Morin-Poulard I, et al
    Multispecies RNA tomography reveals regulators of hematopoietic stem cell birth in the embryonic aorta.
    Blood. 2020 May 26. pii: 457791. doi: 10.1182/blood.2019004446.
    PubMed     Abstract available
    
    
    
83. MENSSEN AJ, Walter MJ
    Genetics of Progression from MDS to Secondary Leukemia.
    Blood. 2020 May 19. pii: 456027. doi: 10.1182/blood.2019000942.
    PubMed     Abstract available
    
    
    
84. ZAMBETTI NA, Firestone AJ, Remsberg JR, Huang BJ, et al
    Genetic disruption of N-RasG12D palmitoylation perturbs hematopoiesis and prevents myeloid transformation in mice.
    Blood. 2020;135:1772-1782.
    PubMed     Abstract available
    
    
    
85. GU H, Chen C, Hao X, Su N, et al
    MDH1-mediated malate-aspartate NADH shuttle maintains the activity levels of fetal liver hematopoietic stem cells.
    Blood. 2020 May 12. pii: 455306. doi: 10.1182/blood.2019003940.
    PubMed     Abstract available
    
    
    
86. GEBRU MT, Atkinson JM, Young M, Zhang L, et al
    Glucocorticoids enhance the anti-leukemic activity of FLT3 inhibitors in FLT3 mutant acute myeloid leukemia.
    Blood. 2020 May 12. pii: 455305. doi: 10.1182/blood.2019003124.
    PubMed     Abstract available
    
    
    
87. ZHU Q, Gao P, Tober J, Bennett L, et al
    Developmental trajectory of pre-hematopoietic stem cell formation from endothelium.
    Blood. 2020 May 11. pii: 455111. doi: 10.1182/blood.2020004801.
    PubMed     Abstract available
    
    
    
88. RAU RE
    SIRPAssing other xenograft murine models?
    Blood. 2020;135:1612-1614.
    PubMed    
    
    
    April 2020
89. APRILE A, Gulino A, Storto M, Villa I, et al
    Hematopoietic stem cell function in beta-thalassemia is impaired and is rescued by targeting the bone marrow niche.
    Blood. 2020 Apr 28. pii: 454666. doi: 10.1182/blood.2019002721.
    PubMed     Abstract available
    
    
    
90. HE H, Xu P, Zhang X, Liao M, et al
    Aging-induced IL27Ra Signaling Impairs Hematopoietic Stem Cells.
    Blood. 2020 Apr 17. pii: 454439. doi: 10.1182/blood.2019003910.
    PubMed     Abstract available
    
    
    
91. SIX E, Guilloux A, Denis A, Lecoules A, et al
    Clonal tracking in gene therapy patients reveals a diversity of human hematopoietic differentiation programs.
    Blood. 2020;135:1219-1231.
    PubMed     Abstract available
    
    
    
92. LIN H, Rothe K, Chen M, Wu A, et al
    The miR-185/PAK6 Axis Predicts Therapy Response and Regulates Survival of Drug-Resistant Leukemic Stem Cells in CML.
    Blood. 2020 Apr 8. pii: 454304. doi: 10.1182/blood.2019003636.
    PubMed     Abstract available
    
    
    
93. CHUTE JP
    Stem cell engraftment within our G(P)RASP.
    Blood. 2020;135:1077-1078.
    PubMed    
    
    
    
94. YEN HJ, Eissa H, Bhatt NS, Huang S, et al
    Patient-Reported Outcomes in Survivors of Childhood Hematologic Malignancies with Hematopoietic Stem Cell Transplant.
    Blood. 2020 Apr 2. pii: 454260. doi: 10.1182/blood.2019003858.
    PubMed     Abstract available
    
    
    March 2020
95. SHIDE K, Kameda T, Kamiunten A, Ozono Y, et al
    Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms.
    Blood. 2020 Mar 27. pii: 454177. doi: 10.1182/blood.2019003358.
    PubMed     Abstract available
    
    
    
96. JINNOUCHI F, Yamauchi T, Yurino A, Nunomura T, et al
    Establishment of a human SIRPA knock-in xenograft mouse model to study human hematopoietic and cancer stem cells.
    Blood. 2020 Mar 23. pii: 452764. doi: 10.1182/blood.2019002194.
    PubMed     Abstract available
    
    
    
97. ZEISER R
    Introduction to How I Treat Series on Common Medical Problems after Allogeneic Stem Cell Transplantation.
    Blood. 2020 Mar 20. pii: 452751. doi: 10.1182/blood.2020005811.
    PubMed    
    
    
    
98. EINSELE H, Ljungman PT, Boeckh MJ
    How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation.
    Blood. 2020 Mar 20. pii: 452747. doi: 10.1182/blood.2019000956.
    PubMed     Abstract available
    
    
    
99. MARTIN PJ
    How I treat steroid-refractory acute graft-versus-host disease.
    Blood. 2020 Mar 20. pii: 452748. doi: 10.1182/blood.2019000960.
    PubMed     Abstract available
    
    
    
100. BOETTCHER S, Wilk CM, Singer J, Beier F, et al
     Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation.
     Blood. 2020 Mar 16. pii: 452703. doi: 10.1182/blood.2019003079.
     PubMed     Abstract available
     
     
     
101. LI L, Mitra A, Cui K, Zhao B, et al
     Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell Acute Lymphoblastic Leukemia.
     Blood. 2020 Mar 16. pii: 452704. doi: 10.1182/blood.2019000794.
     PubMed     Abstract available
     
     
     
102. BRILL A
     Integrin alpha9beta1: a new target to fight thrombosis.
     Blood. 2020;135:787-788.
     PubMed    
     
     
     February 2020
103. ZHANG L, Li J, Xu H, Shao X, et al
     Myc-Miz-1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpalpha and Cebpdelta.
     Blood. 2020 Feb 7. pii: 441057. doi: 10.1182/blood.2019001863.
     PubMed     Abstract available
     
     
     
104. MORALES-HERNANDEZ A, Benaksas C, Chabot A, Caprio C, et al
     GPRASP proteins are critical negative regulators of hematopoietic stem cell transplantation.
     Blood. 2020 Feb 6. pii: 441000. doi: 10.1182/blood.2019003435.
     PubMed     Abstract available
     
     
     January 2020
105. ROWAN C, Pike F, Cooke KR, Krance R, et al
     Assessment of ST2 for risk of death following graft-versus-host disease in the pediatric and adult age groups.
     Blood. 2020 Jan 23. pii: 431344. doi: 10.1182/blood.2019002334.
     PubMed     Abstract available
     
     
     
106. MEYER SE
     MicroRNA immunomodulating therapeutics.
     Blood. 2020;135:155-156.
     PubMed    
     
     
     
107. HALE DA, Krause JR
     Unexpected lymph node finding in a patient with essential thrombocythemia.
     Blood. 2020;135:154.
     PubMed    
     
     
     December 2019
108. ZHU H, Blum R, Bjordahl R, Gaidarova S, et al
     Pluripotent stem cell-derived NK cells with high-affinity non-cleavable CD16a mediate improved anti-tumor activity.
     Blood. 2019 Dec 19. pii: 429991. doi: 10.1182/blood.2019000621.
     PubMed     Abstract available
     
     
     
109. SASCA D, Yun H, Giotopoulos G, Szybinski J, et al
     Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies.
     Blood. 2019;134:2195-2208.
     PubMed     Abstract available
     
     
     
110. PEFFAULT DE LATOUR R, Chevret S, Ruggeri AL, Suarez F, et al
     Romiplostim in Patients undergoing Hematopoietic Stem Cell Transplantation: Results of a Phase I/II multicenter Trial.
     Blood. 2019 Dec 5. pii: 429547. doi: 10.1182/blood.2019000358.
     PubMed    
     
     
     
111. SU YL, Wang X, Mann M, Adamus TP, et al
     Myeloid Cell-Targeted miR-146a Mimic Inhibits NF-kB-Driven Inflammation and Leukemia Progression in Vivo.
     Blood. 2019 Dec 5. pii: 429548. doi: 10.1182/blood.2019002045.
     PubMed     Abstract available
     
     
     November 2019
112. ABRAHAM AA, Block-Abraham D
     Engraftment in utero: it's all in the delivery.
     Blood. 2019;134:1889-1890.
     PubMed    
     
     
     
113. WILKIE AR, Italiano JE
     Platelet alloantibody detection: moving ahead.
     Blood. 2019;134:1887-1888.
     PubMed    
     
     
     
114. KRAUSE DS
     Killing the minotaur in its amazing maze.
     Blood. 2019;134:1884-1885.
     PubMed    
     
     
     
115. ZHANG N, Santoso S, Aster RH, Curtis BR, et al
     Bioengineered iPSC-derived megakaryocytes for the detection of platelet-specific patient alloantibodies.
     Blood. 2019;134:e1-e8.
     PubMed     Abstract available
     
     
     
116. LI Z, Mariani SA, Rodriguez-Seoane C, He W, et al
     A role for macrophages in hematopoiesis in the embryonic head.
     Blood. 2019;134:1929-1940.
     PubMed     Abstract available
     
     
     
117. MCCURDY SR, Luznik L
     How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide.
     Blood. 2019;134:1802-1810.
     PubMed     Abstract available
     
     
     
118. 
     Minnie SA, Kuns RD, Gartlan KH, et al. Myeloma escape after stem cell transplantation is a consequence of T-cell exhaustion and is prevented by TIGIT blockade. Blood. 2018;132(16):1675-1688.
     Blood. 2019;134:1878.
     PubMed    
     
     
     
119. RAO TN, Hansen N, Hilfiker J, Rai S, et al
     JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms.
     Blood. 2019;134:1832-1846.
     PubMed     Abstract available
     
     
     
120. GOLDSTEIN JM, Sengul H, Messemer KA, Fernandez-Alfara M, et al
     Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11.
     Blood. 2019;134:1712-1716.
     PubMed     Abstract available
     
     
     
121. ROBIN M, Wang J, Koster L, Beelen DW, et al
     Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Therapy-Related Myeloid Neoplasm: A Study from the Chronic Malignancies Working Party of the EBMT.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
122. LI A, Wu QV, Hilton T, Pao E, et al
     Soluble C5b-9 As a Prognostic Biomarker for Thrombotic Microangiopathy at the Onset of Graft-Versus-Host Disease.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
123. MIANO M, Eikema DJ, de la Fuente J, Bosman P, et al
     Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT).
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
124. SHOUVAL R, Fein JA, Labopin M, Bazarbachi A, et al
     The Disease-Risk Stratification Scheme (DRSS), a Contemporary Risk-Stratification System for Allogeneic Stem Cell Transplantation.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
125. CIUREA SO, Varma A, Kongtim P, Srour S, et al
     Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
126. HOLTAN S, DeFor TE, Rashidi A, Khoruts A, et al
     Pre-Transplant Serum Claudin-3 Predicts Intestinal Graft-Versus-Host Disease and Non-Relapse Mortality Risk after Allogeneic Hematopoietic Cell Transplantation.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
127. ORAN B, Champlin RE, Wang F, Jeyakumar N, et al
     Donor Clonal Hematopoiesis Increases Risk of Acute Graft Versus Host Disease after Matched Related Transplantation in AML and MDS Patients.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
128. KAWAMURA K, Kanda J, Seo S, Kimura F, et al
     Difference in the Donor Selection Priority in Allogeneic Hematopoietic Stem Cell Transplantation According to Patient Age.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
129. POLVERELLI N, Tura P, Battipaglia G, Lisa G, et al
     Multidimensional Geriatric Assessment for Elderly Patients (>/=60 years) Submitted for Allogeneic Stem Cell Transplantation. a French (Paris) - Italian (Brescia) 10-Years Experience on 228 Patients.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
130. DE JONG CN, Meijer E, Bakunina K, Nur E, et al
     Post-Transplantation Cyclophosphamide after Allogeneic Hematopoietic Stem Cell Transplantation: Results of the Prospective Randomized HOVON-96 Trial in Recipients of Matched Related and Unrelated Donors.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
131. YUSUFOVA N, Teater MR, Soshnev A, Kloetgen A, et al
     Histone 1 Mutations Drive Lymphomagenesis By Inducing Primitive Stem Cell Functions and Epigenetic Instructions through Profound 3D Re-Organization of the B-Cell Genome.
     Blood. 2019;134.
     PubMed     Abstract available
     
     
     
132. KOYAMA M, Hill GR
     The primacy of gastrointestinal tract antigen presenting cells in lethal graft-versus-host disease.
     Blood. 2019 Nov 4. pii: 422723. doi: 10.1182/blood.2019000823.
     PubMed     Abstract available
     
     
     October 2019
133. NARLA A, Mohandas N
     A fork in the road.
     Blood. 2019;134:1484-1485.
     PubMed    
     
     
     
134. XAVIER-FERRUCIO J, Scanlon V, Li X, Zhang PX, et al
     Low iron promotes megakaryocytic commitment of megakaryocytic-erythroid progenitors in humans and mice.
     Blood. 2019;134:1547-1557.
     PubMed     Abstract available
     
     
     
135. 
     Richter M, Saydaminova K, Yumul R, et al. In vivo transduction of primitive mobilized hematopoietic stem cells after intravenous injection of integrating adenovirus vectors. Blood. 2016;128(18):2206-2217.
     Blood. 2019;134:1482.
     PubMed    
     
     
     
136. BURT R, Dey A, Aref S, Aguiar M, et al
     Activated stromal cells transfer mitochondria to rescue acute lymphoblastic leukemia cells from oxidative stress.
     Blood. 2019;134:1415-1429.
     PubMed     Abstract available
     
     
     
137. LEE S, Kim H, You G, Kim YM, et al
     Bone marrow CX3CR1+ mononuclear cells relay a systemic microbiota signal to control hematopoietic progenitors in mice.
     Blood. 2019;134:1312-1322.
     PubMed     Abstract available
     
     
     
138. HUA P, Roy NB, de la Fuente J, Wang G, et al
     Single cell analysis of bone marrow derived CD34+ cells from children with sickle cell disease and thalassemia.
     Blood. 2019 Oct 16. pii: 387151. doi: 10.1182/blood.2019002301.
     PubMed    
     
     
     
139. THANGAVELU G, Du J, Paz KG, Loschi M, et al
     Inhibition of Inositol kinase B controls acute and chronic graft-versus-host disease.
     Blood. 2019 Oct 15. pii: 387148. doi: 10.1182/blood.2019000032.
     PubMed     Abstract available
     
     
     
140. MANSIER O, Kilani B, Guitart AV, Guy A, et al
     Description of a Knock-In Mouse Model of JAK2V617F MPN Emerging from a Minority of Mutated Hematopoietic Stem Cells.
     Blood. 2019 Oct 11. pii: 381159. doi: 10.1182/blood.2019001163.
     PubMed     Abstract available
     
     
     
141. MENDE N, Jolly A, Percin GI, Gunther M, et al
     Prospective isolation of nonhematopoietic cells of the niche and their differential molecular interactions with HSCs.
     Blood. 2019;134:1214-1226.
     PubMed     Abstract available
     
     
     
142. WILKINSON AN, Chang K, Kuns RD, Henden AS, et al
     IL-6 dysregulation originates in dendritic cells and initiates graft-versus-host disease via classical signaling.
     Blood. 2019 Oct 2. pii: blood.2019000396. doi: 10.1182/blood.2019000396.
     PubMed     Abstract available
     
     
     September 2019
143. LOUKOGEORGAKIS SP, Fachin CG, Santos Dias A, Li H, et al
     Donor-Cell Engineering with GSK3 Inhibitor-Loaded Nanoparticles Enhances Engraftment Following in Utero Transplantation.
     Blood. 2019 Sep 30. pii: blood.2019001037. doi: 10.1182/blood.2019001037.
     PubMed     Abstract available
     
     
     
144. O'BYRNE S, Elliott N, Rice S, Buck G, et al
     Discovery of a CD10-negative B-progenitor in human fetal life identifies unique ontogeny-related developmental programs.
     Blood. 2019;134:1059-1071.
     PubMed     Abstract available
     
     
     
145. GONZALEZ-GARCIA S, Mosquera M, Fuentes P, Palumbo T, et al
     IL-7R is essential for leukemia-initiating cell activity and pathogenesis of T-cell acute lymphoblastic leukemia.
     Blood. 2019 Sep 17. pii: blood.2019000982. doi: 10.1182/blood.2019000982.
     PubMed     Abstract available
     
     
     
146. BUENO C, Tejedor JR, Bashford-Rogers R, Gonzalez-Silva L, et al
     Natural history and cell of origin of TC F3-ZN F384 and PTPN11 mutations in monozygotic twins with concordant BCP-ALL.
     Blood. 2019;134:900-905.
     PubMed    
     
     
     
147. PARK CS, Lewis AH, Chen TJ, Bridges CS, et al
     KLF4 Represses DYRK2 Inhibition of Self-renewal and Survival Through c-Myc and p53 in Leukemia Stem/Progenitor Cells.
     Blood. 2019 Sep 12. pii: blood.2018875922. doi: 10.1182/blood.2018875922.
     PubMed     Abstract available
     
     
     August 2019
148. RAMASZ B, Kruger A, Reinhardt J, Sinha A, et al
     Hematopoietic stem cell response to acute thrombocytopenia requires signaling through distinct receptor tyrosine kinases.
     Blood. 2019 Aug 21. pii: blood.2019000721. doi: 10.1182/blood.2019000721.
     PubMed     Abstract available
     
     
     
149. AGGER K, Nishimura K, Miyagi S, Messling JE, et al
     The KDM4/JMJD2 histone demethylases are required for hematopoietic stem cell maintenance.
     Blood. 2019 Aug 21. pii: blood.2019000855. doi: 10.1182/blood.2019000855.
     PubMed     Abstract available
     
     
     
150. OZOG S, Timberlake ND, Hermann K, Garijo O, et al
     Resveratrol trimer enhances gene delivery to hematopoietic stem cells by reducing antiviral restriction at endosomes.
     Blood. 2019 Aug 15. pii: blood.2019000040. doi: 10.1182/blood.2019000040.
     PubMed     Abstract available
     
     
     July 2019
151. STUANI L, Sarry JE
     Help from outside: cysteine to survive in AML.
     Blood. 2019;134:336-338.
     PubMed    
     
     
     
152. SPIVAK JL
     How I treat polycythemia vera.
     Blood. 2019;134:341-352.
     PubMed     Abstract available
     
     
     
153. 
     Pediatric chronic graft-versus-host disease.
     Blood. 2019;134:332.
     PubMed    
     
     
     
154. VASSILIOU GS
     Triple-mutant AML: too clever by HLF?
     Blood. 2019;134:222-224.
     PubMed    
     
     
     
155. VERMA D, Kumar R, Pereira RS, Karantanou C, et al
     Vitamin K antagonism impairs the bone marrow microenvironment and hematopoiesis.
     Blood. 2019;134:227-238.
     PubMed     Abstract available
     
     
     
156. HSU J, Reilly A, Hayes BJ, Clough CA, et al
     Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes.
     Blood. 2019;134:186-198.
     PubMed     Abstract available
     
     
     
157. KAGEYAMA Y, Miwa H, Tawara I, Ohishi K, et al
     A population of CD20(+)CD27(+)CD43(+)CD38(lo/int) B1 cells in PNH are missing GPI-anchored proteins and harbor PIGA mutations.
     Blood. 2019;134:89-92.
     PubMed    
     
     
     
158. KHOO WH, Ledergor G, Weiner A, Roden DL, et al
     A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.
     Blood. 2019;134:30-43.
     PubMed     Abstract available
     
     
     
159. MILL CP, Fiskus W, DiNardo CD, Qian Y, et al
     RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
     Blood. 2019;134:59-73.
     PubMed     Abstract available
     
     
     
160. HU T, Morita K, Hill MC, Jiang Y, et al
     PRDM16s transforms megakaryocyte-erythroid progenitors to acute myeloid leukemia-initiating cells.
     Blood. 2019 Jul 3. pii: blood.2018888255. doi: 10.1182/blood.2018888255.
     PubMed     Abstract available
     
     
     June 2019
161. SINHA RK, Flynn R, Zaiken M, Paz K, et al
     Activated Protein C Ameliorates Chronic Graft-Versus-Host Disease by PAR1-dependent Biased Cell Signaling on T-cells.
     Blood. 2019 Jun 26. pii: blood.2019001259. doi: 10.1182/blood.2019001259.
     PubMed     Abstract available
     
     
     
162. YOSHIMOTO M
     B-1 progenitor acute lymphoid leukemia.
     Blood. 2019;133:2557-2558.
     PubMed    
     
     
     
163. SPERLING S, Fiedler P, Lechner M, Pollithy A, et al
     Chronic CD30 signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.
     Blood. 2019;133:2597-2609.
     PubMed     Abstract available
     
     
     
164. NTZIACHRISTOS P
     PHF6: it is written in the stem cells.
     Blood. 2019;133:2461-2462.
     PubMed    
     
     
     
165. SHIN TH, Baek EJ, Corat MAF, Chen S, et al
     CRISPR/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.
     Blood. 2019;133:2542-2545.
     PubMed    
     
     
     May 2019
166. LE CQ, Myers G, Habara A, Jearawiriyapaisarn N, et al
     Inhibition of LSD1 by small molecule inhibitors stimulates fetal hemoglobin synthesis.
     Blood. 2019;133:2455-2459.
     PubMed    
     
     
     
167. MACK EA, Stein SJ, Rome KS, Xu L, et al
     Trib1 regulates eosinophil lineage commitment and identity by restraining the neutrophil program.
     Blood. 2019;133:2413-2426.
     PubMed     Abstract available
     
     
     
168. SYKES SM
     NCAM1 supports therapy resistance and LSC function in AML.
     Blood. 2019;133:2247-2248.
     PubMed    
     
     
     
169. XU S, Luk K, Yao Q, Shen AH, et al
     Editing aberrant splice sites efficiently restores beta-globin expression in beta-thalassemia.
     Blood. 2019;133:2255-2262.
     PubMed     Abstract available
     
     
     
170. JONES CL, Stevens BM, D'Alessandro A, Culp-Hill R, et al
     Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.
     Blood. 2019 May 17. pii: blood.2019898114. doi: 10.1182/blood.2019898114.
     PubMed     Abstract available
     
     
     
171. PASSAMONTI F
     Stem cell transplant in MF: it's time to personalize.
     Blood. 2019;133:2118-2120.
     PubMed    
     
     
     
172. COSSIO I, Lucas D, Hidalgo A
     Neutrophils as regulators of the hematopoietic niche.
     Blood. 2019;133:2140-2148.
     PubMed     Abstract available
     
     
     
173. GARG S, Reyes-Palomares A, He L, Bergeron A, et al
     Hepatic leukemia factor is a novel leukemic stem cell regulator in DNMT3A, NPM1, and FLT3-ITD triple-mutated AML.
     Blood. 2019 May 10. pii: blood.2018862383. doi: 10.1182/blood.2018862383.
     PubMed     Abstract available
     
     
     
174. MANZ MG, Russkamp NF
     Selective CD117(+) HSC exchange therapy.
     Blood. 2019;133:2007-2009.
     PubMed    
     
     
     
175. ALVARADO LJ, Huntsman HD, Cheng H, Townsley DM, et al
     Eltrombopag maintains human hematopoietic stem and progenitor cells under inflammatory conditions mediated by IFN-gamma.
     Blood. 2019;133:2043-2055.
     PubMed     Abstract available
     
     
     
176. KWON HS, Logan AC, Chhabra A, Pang WW, et al
     Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice.
     Blood. 2019;133:2104-2108.
     PubMed    
     
     
     
177. BEERMAN I
     Loss of hematopoietic diversity with age.
     Blood. 2019;133:1921-1922.
     PubMed    
     
     
     
178. GANUZA M, Hall T, Finkelstein D, Wang YD, et al
     The global clonal complexity of the murine blood system declines throughout life and after serial transplantation.
     Blood. 2019;133:1927-1942.
     PubMed     Abstract available
     
     
     April 2019
179. KUROTAKI D, Kawase W, Sasaki H, Nakabayashi J, et al
     Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.
     Blood. 2019;133:1803-1813.
     PubMed     Abstract available
     
     
     
180. YIN M, Chung YJ, Lindsley RC, Walker RL, et al
     Engineered Bcor mutations lead to acute leukemia of progenitor B-1 lymphocyte origin in a sensitized background.
     Blood. 2019 Apr 16. pii: blood.2018864173. doi: 10.1182/blood.2018864173.
     PubMed     Abstract available
     
     
     
181. ARMAND P, Chen YB, Redd RA, Joyce RM, et al
     PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation.
     Blood. 2019 Apr 5. pii: blood.2019000215. doi: 10.1182/blood.2019000215.
     PubMed     Abstract available
     
     
     
182. SINHA S, Dwivedi TR, Yengkhom R, Bheemsetty VA, et al
     Asrij/OCIAD1 suppresses CSN5-mediated p53 degradation and maintains mouse hematopoietic stem cell quiescence.
     Blood. 2019 Apr 5. pii: blood.2019000530. doi: 10.1182/blood.2019000530.
     PubMed     Abstract available
     
     
     
183. NAKAMURA S, Yokoyama K, Shimizu E, Yusa N, et al
     Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.
     Blood. 2019 Apr 1. pii: blood-2018-10-880690. doi: 10.1182/blood-2018-10-880690.
     PubMed     Abstract available
     
     
     March 2019
184. GOODELL MA, Bodine DM
     Single-cell technology meets hematology: introduction to a review series.
     Blood. 2019;133:1387-1388.
     PubMed    
     
     
     
185. PSAILA B, Mead AJ
     Single-cell approaches reveal novel cellular pathways for megakaryocyte and erythroid differentiation.
     Blood. 2019;133:1427-1435.
     PubMed     Abstract available
     
     
     
186. WATCHAM S, Kucinski I, Gottgens B
     New insights into hematopoietic differentiation landscapes from single-cell RNA sequencing.
     Blood. 2019;133:1415-1426.
     PubMed     Abstract available
     
     
     
187. NANGALIA J, Mitchell E, Green AR
     Clonal approaches to understanding the impact of mutations on hematologic disease development.
     Blood. 2019;133:1436-1445.
     PubMed     Abstract available
     
     
     
188. LOEFFLER D, Schroeder T
     Understanding cell fate control by continuous single-cell quantification.
     Blood. 2019;133:1406-1414.
     PubMed     Abstract available
     
     
     
189. MIYAGI S, Sroczynska P, Kato Y, Nakajima-Takagi Y, et al
     The chromatin binding protein Phf6 restricts the self-renewal of hematopoietic stem cells.
     Blood. 2019 Mar 27. pii: blood.2019000468. doi: 10.1182/blood.2019000468.
     PubMed     Abstract available
     
     
     
190. FOK WC, Shukla S, Vessoni AT, Brenner KA, et al
     Posttranscriptional modulation of TERC by PAPD5 inhibition rescues hematopoietic development in dyskeratosis congenita.
     Blood. 2019;133:1308-1312.
     PubMed     Abstract available
     
     
     
191. PRONK E, Raaijmakers MHGP
     The mesenchymal niche in MDS.
     Blood. 2019;133:1031-1038.
     PubMed     Abstract available
     
     
     February 2019
192. FILIPPI MD, Ghaffari S
     Mitochondria in the maintenance of hematopoietic stem cells new perspectives and opportunities.
     Blood. 2019 Feb 26. pii: blood-2018-10-808873. doi: 10.1182/blood-2018-10-808873
     PubMed     Abstract available
     
     
     
193. KAUFMANN KB, Garcia-Prat L, Liu Q, Ng SWK, et al
     A stemness screen reveals C3orf54/INKA1 as a promoter of human leukemia stem cell latency.
     Blood. 2019 Feb 22. pii: blood-2018-10-881441. doi: 10.1182/blood-2018-10-881441
     PubMed     Abstract available
     
     
     
194. YU S, Jiang T, Jia D, Han Y, et al
     BCAS2 is essential for hematopoietic stem and progenitor cell maintenance during zebrafish embryogenesis.
     Blood. 2019;133:805-815.
     PubMed     Abstract available
     
     
     
195. ETZRODT M, Ahmed N, Hoppe PS, Loeffler D, et al
     Inflammatory signals directly instruct PU.1 in HSCs via TNF.
     Blood. 2019;133:816-819.
     PubMed     Abstract available
     
     
     
196. BALDUINI A
     Megakaryocytes from fat: a new recipe for platelets.
     Blood. 2019;133:623-625.
     PubMed    
     
     
     
197. GAGELMANN N, Ditschkowski M, Bogdanov R, Bredin S, et al
     Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation.
     Blood. 2019 Feb 13. pii: blood-2018-12-890889. doi: 10.1182/blood-2018-12-890889
     PubMed     Abstract available
     
     
     
198. DONAGHY R, Han X, Rozenova K, Lv K, et al
     The BRISC de-ubiquitinating enzyme complex limits hematopoietic stem cell expansion by regulating JAK2 K63-ubiquitination.
     Blood. 2019 Feb 12. pii: blood-2018-10-877563. doi: 10.1182/blood-2018-10-877563
     PubMed     Abstract available
     
     
     
199. MCRAE HM, Garnham AL, Hu Y, Witkowski MT, et al
     PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia.
     Blood. 2019 Feb 12. pii: blood-2018-07-860726. doi: 10.1182/blood-2018-07-860726
     PubMed     Abstract available
     
     
     
200. PANG WW, Czechowicz A, Logan AC, Bhardwaj R, et al
     Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice.
     Blood. 2019 Feb 11. pii: blood-2018-06-858159. doi: 10.1182/blood-2018-06-858159
     PubMed     Abstract available
     
     
     January 2019
201. DOTY RT, Yan X, Lausted C, Munday AD, et al
     Single-cell analyses demonstrate that a heme-GATA1 feedback loop regulates red cell differentiation.
     Blood. 2019;133:457-469.
     PubMed     Abstract available
     
     
     
202. KOHLSCHEEN S, Schenk F, Rommel MGE, Cullmann K, et al
     Endothelial protein C receptor supports hematopoietic stem cell engraftment and expansion in Mpl-deficient mice.
     Blood. 2019 Jan 25. pii: blood-2018-03-837344. doi: 10.1182/blood-2018-03-837344
     PubMed     Abstract available
     
     
     
203. SARANTOPOULOS S, Cardones AR, Sullivan KM
     How we treat refractory chronic graft-versus-host disease.
     Blood. 2019 Jan 23. pii: blood-2018-04-785899. doi: 10.1182/blood-2018-04-785899
     PubMed     Abstract available
     
     
     
204. O'LEARY HA
     Timing's everything in light, location, and cells.
     Blood. 2019;133:186-187.
     PubMed    
     
     
     
205. ORCHARD PJ, Nascene DR, Miller WP, Gupta A, et al
     Successful donor engraftment and repair of the blood brain barrier in cerebral adrenoleukodystrophy.
     Blood. 2019 Jan 11. pii: blood-2018-11-887240. doi: 10.1182/blood-2018-11-887240
     PubMed     Abstract available
     
     
     
206. WAGNER PN, Shi Q, Salisbury-Ruf CT, Zou J, et al
     Increased Ripk1-mediated bone marrow necroptosis leads to myelodysplasia and bone marrow failure in mice.
     Blood. 2019;133:107-120.
     PubMed     Abstract available
     
     
     
207. KNAPP DJHF, Hammond CA, Wang F, Aghaeepour N, et al
     A topological view of human CD34+ cell state trajectories from integrated single-cell output and proteomic data.
     Blood. 2019 Jan 8. pii: blood-2018-10-878025. doi: 10.1182/blood-2018-10-878025.
     PubMed     Abstract available
     
     
     December 2018
208. BORGES L, Oliveira VKP, Baik J, Bendall S, et al
     Serial transplantation reveals a critical role for endoglin in hematopoietic stem cell quiescence.
     Blood. 2018 Dec 28. pii: blood-2018-09-874677. doi: 10.1182/blood-2018-09-874677
     PubMed     Abstract available
     
     
     
209. ANDOR N, Simonds EF, Czerwinski DK, Chen J, et al
     Single-cell RNA-Seq of lymphoma cancers reveals malignant B cell types and co-expression of T cell immune checkpoints.
     Blood. 2018 Dec 27. pii: blood-2018-08-862292. doi: 10.1182/blood-2018-08-862292
     PubMed     Abstract available
     
     
     November 2018
210. KLAIRMONT MM, Choi JK
     Mixed-phenotype acute leukemia, T/megakaryoblastic.
     Blood. 2018;132:2418.
     PubMed    
     
     
     
211. TOZAWA K, Ono-Uruga Y, Yazawa M, Mori T, et al
     Unique megakaryocytes and platelets from novel human adipose-derived mesenchymal stem cell line.
     Blood. 2018 Nov 28. pii: blood-2018-04-842641. doi: 10.1182/blood-2018-04-842641
     PubMed     Abstract available
     
     
     
212. JIANG W, Lee SH
     Microgranular variant of acute promyelocytic leukemia with cytoplasmic projections resembling micromegakaryocytes.
     Blood. 2018;132:2314.
     PubMed    
     
     
     
213. DUCAMP S, Fleming MD
     The molecular genetics of sideroblastic anemia.
     Blood. 2018 Nov 6. pii: blood-2018-08-815951. doi: 10.1182/blood-2018-08-815951.
     PubMed     Abstract available
     
     
     
214. ABDUL-AZIZ AM, Sun Y, Hellmich C, Marlein CR, et al
     Acute myeloid leukemia induces pro-tumoral p16INK4a driven senescence in the bone marrow microenvironment.
     Blood. 2018 Nov 6. pii: blood-2018-04-845420. doi: 10.1182/blood-2018-04-845420.
     PubMed     Abstract available
     
     
     October 2018
215. TSAI JJ, Velardi E, Shono Y, Argyropoulos KV, et al
     Nrf2 regulates CD4(+) T cell-induced acute graft-versus-host disease in mice.
     Blood. 2018 Oct 31. pii: blood-2017-10-812941. doi: 10.1182/blood-2017-10-812941
     PubMed     Abstract available
     
     
     
216. GARCIA-GARCIA A, Korn C, Garcia-Fernandez M, Domingues O, et al
     Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes.
     Blood. 2018 Oct 25. pii: blood-2018-08-867648. doi: 10.1182/blood-2018-08-867648
     PubMed     Abstract available
     
     
     
217. PAZ K, Flynn R, Du J, Qi J, et al
     Small-molecule BCL6 inhibitor effectively treats mice with non-sclerodermatous chronic graft-versus-host disease.
     Blood. 2018 Oct 2. pii: blood-2018-03-839993. doi: 10.1182/blood-2018-03-839993.
     PubMed     Abstract available
     
     
     September 2018
218. MCLAUGHLIN LP, Rouce R, Gottschalk S, Torrano V, et al
     EBV/LMP-specific T cells maintain remissions of T and B cell EBV lymphomas after allogeneic bone marrow transplantation.
     Blood. 2018 Sep 27. pii: blood-2018-07-863654. doi: 10.1182/blood-2018-07-863654
     PubMed     Abstract available
     
     
     
219. SWIMM A, Giver CR, DeFilipp Z, Rangaraju S, et al
     Indoles derived from intestinal microbiota act via type I interferon signaling to limit Graft-versus-Host-Disease.
     Blood. 2018 Sep 26. pii: blood-2018-03-838193. doi: 10.1182/blood-2018-03-838193
     PubMed     Abstract available
     
     
     
220. QU X, Zhang S, Wang S, Wang Y, et al
     TET2 deficiency leads to stem cell factor dependent clonal expansion of dysfunctional erythroid progenitors.
     Blood. 2018 Sep 25. pii: blood-2018-05-853291. doi: 10.1182/blood-2018-05-853291
     PubMed     Abstract available
     
     
     
221. MUENCH DE, Ferchen K, Velu CS, Pradhan K, et al
     SKI controls MDS-associated chronic TGFbeta signaling, aberrant splicing, and stem cell fitness.
     Blood. 2018 Sep 24. pii: blood-2018-06-860890. doi: 10.1182/blood-2018-06-860890
     PubMed     Abstract available
     
     
     
222. RADOJCIC V, Paz K, Chung J, Du J, et al
     Notch signaling mediated by Delta-like1/4 ligands controls the pathogenesis of chronic graft-versus-host disease in mice.
     Blood. 2018 Sep 4. pii: blood-2018-03-841155. doi: 10.1182/blood-2018-03-841155.
     PubMed     Abstract available
     
     
     August 2018
223. 
     Scheicher R, Hoelbl-Kovacic A, Bellutti F, et al. CDK6 as a key regulator of hematopoietic and leukemic stem cell activation. Blood. 2015;125(1):90-101.
     Blood. 2018;132:978-979.
     PubMed    
     
     
     
224. MINNIE SA, Kuns RD, Gartlan KH, Zhang P, et al
     Myeloma-escape after stem cell transplantation is a consequence of T cell exhaustion and is prevented by TIGIT blockade.
     Blood. 2018 Aug 28. pii: blood-2018-01-825240. doi: 10.1182/blood-2018-01-825240
     PubMed     Abstract available
     
     
     
225. PAWELEC GP
     CASIN the joint: immune aging at the stem cell level.
     Blood. 2018;132:553-554.
     PubMed    
     
     
     July 2018
226. HOFER T, Rodewald HR
     Differentiation-based model of hematopoietic stem cell functions and lineage pathways.
     Blood. 2018 Jul 24. pii: blood-2018-03-791517. doi: 10.1182/blood-2018-03-791517
     PubMed     Abstract available
     
     
     
227. SHEPHERD MS, Li J, Wilson NK, Oedekoven CA, et al
     Single cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal.
     Blood. 2018 Jul 10. pii: blood-2017-12-821066. doi: 10.1182/blood-2017-12-821066
     PubMed     Abstract available
     
     
     June 2018
228. HU M, Zeng H, Chen S, Xu Y, et al
     SRC-3 is involved in maintaining hematopoietic stem cell quiescence by regulation of mitochondrial metabolism in mice.
     Blood. 2018 Jun 29. pii: blood-2018-02-831669. doi: 10.1182/blood-2018-02-831669
     PubMed     Abstract available
     
     
     
229. KAUR S, Raggatt LJ, Millard SM, Wu AC, et al
     Self-repopulating recipient bone marrow resident macrophages promote long-term hematopoietic stem cell engraftment.
     Blood. 2018 Jun 26. pii: blood-2018-01-829663. doi: 10.1182/blood-2018-01-829663
     PubMed     Abstract available
     
     
     
230. SMEETS MF, Tan SY, Xu JJ, Anande G, et al
     Srsf2(P95H) initiates myeloid bias and myelodysplastic/myeloproliferative syndrome (MDS/MPN) from hemopoietic stem cells.
     Blood. 2018 Jun 14. pii: blood-2018-04-845602. doi: 10.1182/blood-2018-04-845602
     PubMed     Abstract available
     
     
     
231. SAROSIEK S, Quillen K, Sloan JM, Brauneis D, et al
     Heparin-induced thrombocytopenia and thrombosis during high dose melphalan and autologous stem cell transplantation.
     Blood. 2018 Jun 14. pii: blood-2018-03-838672. doi: 10.1182/blood-2018-03-838672
     PubMed    
     
     
     
232. LEINS H, Mulaw M, Eiwen K, Sakk V, et al
     Aged murine hematopoietic stem cells drive aging-associated immune remodeling.
     Blood. 2018 Jun 11. pii: blood-2018-02-831065. doi: 10.1182/blood-2018-02-831065
     PubMed     Abstract available
     
     
     May 2018
233. LI C, Psatha N, Sova P, Gil S, et al
     Reactivation of gamma-globin in adult beta-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing.
     Blood. 2018 May 22. pii: blood-2018-03-838540. doi: 10.1182/blood-2018-03-838540
     PubMed     Abstract available
     
     
     
234. BUSCARLET M, Provost S, Feroz Zada Y, Bourgoin V, et al
     Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A.
     Blood. 2018 May 15. pii: blood-2018-01-829937. doi: 10.1182/blood-2018-01-829937
     PubMed     Abstract available
     
     
     
235. MIGGELBRINK AM, Logan BR, Buckley RH, Parrott RE, et al
     B cell differentiation and IL-21 response in IL2RG/JAK3 SCID patients after hematopoietic stem cell transplantation.
     Blood. 2018 May 4. pii: blood-2017-10-809822. doi: 10.1182/blood-2017-10-809822.
     PubMed     Abstract available
     
     
     
236. BLAZAR BR, MacDonald KPA, Hill GR
     Immune regulatory cell infusion for graft-versus-host disease prevention and therapy.
     Blood. 2018 May 4. pii: blood-2017-11-785865. doi: 10.1182/blood-2017-11-785865.
     PubMed     Abstract available
     
     
     April 2018
237. SCHMITZ N, Lenz G, Stelljes M
     Allogeneic hematopoietic stem cell transplantation (HSCT) for T-cell lymphomas.
     Blood. 2018 Apr 26. pii: blood-2018-01-791335. doi: 10.1182/blood-2018-01-791335
     PubMed     Abstract available
     
     
     
238. HEERY DM
     A fellowship of Ring1 maintains AML stem cells.
     Blood. 2018;131:1771-1773.
     PubMed    
     
     
     
239. KRAUSE DS
     Et tu, E2F1? The assassins of CML stem cells.
     Blood. 2018;131:1499-1500.
     PubMed    
     
     
     March 2018
240. OHWADA C, Sakaida E, Kawajiri-Manako C, Nagao Y, et al
     Long-Term Evaluation of Physical Improvement and Survival of Autologous Stem Cell Transplantation in POEMS Syndrome.
     Blood. 2018 Mar 29. pii: blood-2017-07-795385. doi: 10.1182/blood-2017-07-795385
     PubMed    
     
     
     
241. ARNDT K, Kranz A, Fohgrub J, Jolly A, et al
     SETD1A protects HSCs from activation-induced functional decline in vivo.
     Blood. 2018;131:1311-1324.
     PubMed     Abstract available
     
     
     
242. NAHAS MR, Soiffer RJ, Kim HT, Alyea E, et al
     Phase I clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
     Blood. 2018 Mar 16. pii: blood-2017-05-780239. doi: 10.1182/blood-2017-05-780239
     PubMed     Abstract available
     
     
     
243. YU KR, Espinoza DA, Wu C, Truitt L, et al
     The impact of aging on primate hematopoiesis as interrogated by clonal tracking.
     Blood. 2018;131:1195-1205.
     PubMed     Abstract available
     
     
     
244. WU Y, Schutt S, Paz K, Zhang M, et al
     MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice.
     Blood. 2018 Mar 12. pii: blood-2017-06-789321. doi: 10.1182/blood-2017-06-789321
     PubMed     Abstract available
     
     
     
245. FREIRE PR, Conneely OM
     NR4A1 and NR4A3 restrict HSC proliferation via reciprocal regulation of C/EBPalpha and inflammatory signaling.
     Blood. 2018;131:1081-1093.
     PubMed     Abstract available
     
     
     February 2018
246. HULSDUNKER J, Ottmuller KJ, Neeff HP, Koyama M, et al
     Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onset.
     Blood. 2018 Feb 20. pii: blood-2017-10-812891. doi: 10.1182/blood-2017-10-812891
     PubMed     Abstract available
     
     
     
247. MAGENAU JM, Goldstein SC, Peltier D, Soiffer RJ, et al
     alpha1-Antitrypsin Infusion for treatment of Steroid Resistant Acute Graft-versus-Host Disease.
     Blood. 2018 Feb 2. pii: blood-2017-11-815746. doi: 10.1182/blood-2017-11-815746.
     PubMed     Abstract available
     
     
     
248. ZEISER R, Sarantopoulos S, Blazar BR
     B-cell targeting in chronic Graft-versus-Host disease.
     Blood. 2018 Feb 1. pii: blood-2017-11-784017. doi: 10.1182/blood-2017-11-784017.
     PubMed     Abstract available
     
     
     
249. SHLUSH LI
     Age-related clonal hematopoiesis.
     Blood. 2018;131:496-504.
     PubMed     Abstract available
     
     
     January 2018
250. SHIMA H, Takamatsu-Ichihara E, Shino M, Yamagata K, et al
     Ring1A and Ring 1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.
     Blood. 2018 Jan 25. pii: blood-2017-05-787226. doi: 10.1182/blood-2017-05-787226
     PubMed     Abstract available
     
     
     
251. TAKAHASHI S, Hashimoto D, Hayase E, Ogasawara R, et al
     Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease.
     Blood. 2018 Jan 23. pii: blood-2017-06-792614. doi: 10.1182/blood-2017-06-792614
     PubMed     Abstract available
     
     
     
252. YAMAKAWA T, Ohigashi H, Hashimoto D, Hayase E, et al
     Vitamin A-coupled liposomes containing siRNA against HSP47 ameliorate skin fibrosis in chronic graft-versus-host disease.
     Blood. 2018 Jan 23. pii: blood-2017-04-779934. doi: 10.1182/blood-2017-04-779934
     PubMed     Abstract available
     
     
     
253. COOLEY S, Parham P, Miller JS
     Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.
     Blood. 2018 Jan 22. pii: blood-2017-08-752170. doi: 10.1182/blood-2017-08-752170
     PubMed     Abstract available
     
     
     
254. PFEIFER H, Raum K, Markovic S, Nowak V, et al
     Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation.
     Blood. 2018 Jan 18. pii: blood-2017-07-796862. doi: 10.1182/blood-2017-07-796862
     PubMed     Abstract available
     
     
     
255. DU J, Flynn R, Paz K, Ren HG, et al
     Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.
     Blood. 2018 Jan 18. pii: blood-2017-08-800623. doi: 10.1182/blood-2017-08-800623
     PubMed     Abstract available
     
     
     
256. GERRI C, Marass M, Rossi A, Stainier DYR, et al
     Hif-1alpha and Hif-2alpha regulate hemogenic endothelium and hematopoietic stem cell formation in zebrafish.
     Blood. 2018 Jan 16. pii: blood-2017-07-797795. doi: 10.1182/blood-2017-07-797795
     PubMed     Abstract available
     
     
     December 2017
257. GROCKOWIAK E, Laperrousaz B, Jeanpierre S, Voeltzel T, et al
     Immature CML cells implement a BMP autocrine loop to escape TKI treatment.
     Blood. 2017;130:2860-2871.
     PubMed     Abstract available
     
     
     
258. LI J, Prins D, Park HJ, Grinfeld J, et al
     Mutant calreticulin knock-in mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage.
     Blood. 2017 Dec 27. pii: blood-2017-09-806356. doi: 10.1182/blood-2017-09-806356
     PubMed     Abstract available
     
     
     
259. FOX TA, Chakraverty R, Burns S, Carpenter B, et al
     Successful outcome following allogeneic hematopoietic stem cell transplantation in adults with primary immunodeficiency.
     Blood. 2017 Dec 26. pii: blood-2017-09-807487. doi: 10.1182/blood-2017-09-807487
     PubMed     Abstract available
     
     
     
260. ZHAO X, Gao S, Wu Z, Kajigaya S, et al
     Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells.
     Blood. 2017;130:2762-2773.
     PubMed     Abstract available
     
     
     
261. ZEIDAN AM, Stahl M, Hu X, Wang R, et al
     Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation.
     Blood. 2017 Dec 19. pii: blood-2017-10-811729. doi: 10.1182/blood-2017-10-811729
     PubMed    
     
     
     
262. MORISHIMA S, Shiina T, Suzuki S, Ogawa S, et al
     Evolutionary basis of HLA-DPB1 alleles affects acute GVHD in unrelated donor stem cell transplantation.
     Blood. 2017 Dec 15. pii: blood-2017-08-801449. doi: 10.1182/blood-2017-08-801449
     PubMed     Abstract available
     
     
     
263. SHIOZAWA Y, Malcovati L, Galli A, Pellagatti A, et al
     Gene expression and risk of leukemic transformation in myelodysplasia.
     Blood. 2017;130:2642-2653.
     PubMed     Abstract available
     
     
     
264. MIKKILINENI L, Kochenderfer JN
     Chimeric antigen receptor T-cell therapies for multiple myeloma.
     Blood. 2017;130:2594-2602.
     PubMed     Abstract available
     
     
     
265. PRATS-MARTIN C, Morales-Camacho RM
     Circulating hypergranular neoplastic cells: not always leukemic promyelocytes.
     Blood. 2017;130:2689.
     PubMed    
     
     
     
266. HETZEL M, Mucci A, Blank P, Nguyen AHH, et al
     Hematopoietic stem cell gene therapy for IFNgammaR1 deficiency protects mice from mycobacterial infections.
     Blood. 2017 Dec 12. pii: blood-2017-10-812859. doi: 10.1182/blood-2017-10-812859
     PubMed     Abstract available
     
     
     
267. JAIN R, Sheridan JM, Policheni A, Heinlein M, et al
     A critical epithelial survival axis regulated by MCL-1 maintains thymic function in mice.
     Blood. 2017;130:2504-2515.
     PubMed     Abstract available
     
     
     
268. TAI X
     MCL-1 keeps a charming home for thymocytes.
     Blood. 2017;130:2448-2450.
     PubMed    
     
     
     November 2017
269. KON A, Yamazaki S, Nannya Y, Kataoka K, et al
     Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice.
     Blood. 2017 Nov 16. pii: blood-2017-01-762393. doi: 10.1182/blood-2017-01-762393
     PubMed     Abstract available
     
     
     
270. DE HAAN G, Lazare S
     Aging of hematopoietic stem cells.
     Blood. 2017 Nov 15. pii: blood-2017-06-746412. doi: 10.1182/blood-2017-06-746412
     PubMed     Abstract available
     
     
     
271. WANG KS, Kim HT, Nikiforow S, Heubeck AT, et al
     Antibodies Targeting Surface Membrane Antigens in Patients with Chronic Graft-Versus-Host Disease.
     Blood. 2017 Nov 14. pii: blood-2017-08-801001. doi: 10.1182/blood-2017-08-801001
     PubMed     Abstract available
     
     
     October 2017
272. HUA WK, Qi J, Cai Q, Carnahan E, et al
     HDAC8 regulates long-term hematopoietic stem cell maintenance under stress by modulating p53 activity.
     Blood. 2017 Oct 30. pii: blood-2017-03-771386. doi: 10.1182/blood-2017-03-771386
     PubMed     Abstract available
     
     
     
273. BOUVIER S, Martin M
     Atypical monoblasts with micronuclei.
     Blood. 2017;130:1958.
     PubMed    
     
     
     
274. DOSSA RG, Cunningham T, Sommermeyer D, Medina-Rodriguez I, et al
     Development of T cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse.
     Blood. 2017 Oct 19. pii: blood-2017-07-791608. doi: 10.1182/blood-2017-07-791608
     PubMed     Abstract available
     
     
     
275. DAHLIN JS, Ekoff M, Grootens J, Lof L, et al
     KIT signaling is dispensable for human mast cell progenitor development.
     Blood. 2017;130:1785-1794.
     PubMed     Abstract available
     
     
     
276. MARLEIN CR, Zaitseva L, Piddock RE, Robinson SD, et al
     NADPH oxidase-2 derived superoxide drives mitochondrial transfer from bone marrow stromal cells to leukemic blasts.
     Blood. 2017;130:1649-1660.
     PubMed     Abstract available
     
     
     
277. LAPALOMBELLA R
     Mitochondria on the move: BMSCs fuel AML energy.
     Blood. 2017;130:1603-1604.
     PubMed    
     
     
     
278. HASHEM H, Kumar AR, Muller I, Babor F, et al
     Hematopoietic stem cell transplantation rescues the hematological, immunological and vascular phenotype in DADA2.
     Blood. 2017 Oct 3. pii: blood-2017-07-798660. doi: 10.1182/blood-2017-07-798660.
     PubMed     Abstract available
     
     
     September 2017
279. MARTIN-PARDILLOS A, Tsaalbi-Shtylik A, Chen S, Lazare S, et al
     Genomic and functional integrity of the hematopoietic system requires tolerance of oxidative DNA lesions.
     Blood. 2017;130:1523-1534.
     PubMed     Abstract available
     
     
     
280. ROELENS M, Delord M, Ram-Wolff C, Marie-Cardine A, et al
     Circulating and skin-derived Sezary cells: clonal but with phenotypic plasticity.
     Blood. 2017;130:1468-1471.
     PubMed    
     
     
     
281. ZURLI V, Wimmer G, Cattaneo F, Candi V, et al
     Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia.
     Blood. 2017 Sep 20. pii: blood-2017-03-775858. doi: 10.1182/blood-2017-03-775858
     PubMed     Abstract available
     
     
     
282. MIKLOS D, Cutler CS, Arora M, Waller EK, et al
     Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
     Blood. 2017 Sep 18. pii: blood-2017-07-793786. doi: 10.1182/blood-2017-07-793786
     PubMed     Abstract available
     
     
     
283. LIN S, Ptasinska A, Chen X, Shrestha M, et al
     A FOXO1-induced oncogenic network defines the AML1-ETO preleukemic program.
     Blood. 2017;130:1213-1222.
     PubMed     Abstract available
     
     
     
284. AHCI M, Toffalori C, Bouwmans E, Crivello P, et al
     A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT.
     Blood. 2017;130:1270-1273.
     PubMed    
     
     
     August 2017
285. MACHLUS KR, Wu SK, Vijey P, Soussou TS, et al
     Selinexor-induced thrombocytopenia results from inhibition of thrombopoietin signaling in early megakaryopoiesis.
     Blood. 2017;130:1132-1143.
     PubMed     Abstract available
     
     
     
286. DOVEY OM, Cooper JL, Mupo A, Grove CS, et al
     Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.
     Blood. 2017 Aug 23. pii: blood-2017-01-760595. doi: 10.1182/blood-2017-01-760595
     PubMed     Abstract available
     
     
     
287. DUTTA A, Hutchison RE, Mohi G
     Hmga2 promotes the development of myelofibrosis in Jak2V617F knockin mice by enhancing TGF-beta1 and Cxcl12 pathways.
     Blood. 2017;130:920-932.
     PubMed     Abstract available
     
     
     
288. KATAYAMA S, Suzuki M, Yamaoka A, Keleku-Lukwete N, et al
     GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis.
     Blood. 2017;130:908-919.
     PubMed     Abstract available
     
     
     
289. MIZUKAWA B, O'Brien E, Moreira DC, Wunderlich M, et al
     Cell polarity determinant CDC42 controls division symmetry to block leukemia cell differentiation.
     Blood. 2017 Aug 4. pii: blood-2016-12-758458. doi: 10.1182/blood-2016-12-758458.
     PubMed     Abstract available
     
     
     July 2017
290. THAKRAL B, Muzzafar T
     Diagnosing therapy-related acute myeloid leukemia with 8% blasts in bone marrow with concomitant plasma cell myeloma.
     Blood. 2017;130:231.
     PubMed    
     
     
     June 2017
291. VO KK, Jarocha DJ, Lyde RB, Hayes V, et al
     FLI1 level during megakaryopoiesis affects thrombopoiesis and platelet biology.
     Blood. 2017;129:3486-3494.
     PubMed     Abstract available
     
     
     
292. QUESADA AE, Kanagal-Shamanna R
     Targeted therapy-induced differentiation of acute myeloid leukemia blasts.
     Blood. 2017;129:3503.
     PubMed    
     
     
     May 2017
293. MAN N, Tan Y, Sun XJ, Liu F, et al
     Caspase-3 controls AML1-ETO-driven leukemogenesis via autophagy modulation in a ULK1-dependent manner.
     Blood. 2017;129:2782-2792.
     PubMed     Abstract available
     
     
     April 2017
294. DOWSE RT, Ireland RM
     Variant ZBTB16-RARA translocation: morphological changes predict cytogenetic variants of APL.
     Blood. 2017;129:2038.
     PubMed    
     
     
     March 2017
295. BUSQUE L
     HSPCs are marathon and not sprint relay athletes.
     Blood. 2017;129:1406-1407.
     PubMed    
     
     
     February 2017
296. POURABDOLLAH M, Chang H
     Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance.
     Blood. 2017;129:918.
     PubMed    
     
     
     January 2017
297. XU J, Li S
     Blasts with abundant cytoplasmic granules: acute myeloid leukemia or granular acute lymphoblastic leukemia?
     Blood. 2017;129:537.
     PubMed    
     
     
     November 2016
298. GARGIULO L, Zaimoku Y, Scappini B, Maruyama H, et al
     Glycosylphosphatidylinositol-specific T cells,IFNgamma-producing T cells,and pathogenesis of idiopathic aplastic anemia.
     Blood. 2016 Nov 30. pii: blood-2016-09-740845.
     PubMed    
     
     
     September 2016
299. KOTROVA M, Musilova A, Stuchly J, Fiser K, et al
     Distinct bilineal leukemia immunophenotypes are not genetically determined.
     Blood. 2016 Sep 13. pii: blood-2016-07-725861.
     PubMed    
     
     
     June 2016
300. 
     Whang J, Frei E III, Tjio JH, Carbone PP, Brecher G. The distribution of the Philadelphia chromosome in patients with chronic myelogenous leukemia. Blood. 1963;22(6):664-673.
     Blood. 2016;127:3295.
     PubMed    
     
     
     April 2016
301. JOHNSON SM, Dempsey C, Chadwick A, Harrison S, et al
     Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia.
     Blood. 2016 Apr 20. pii: blood-2015-12-688051.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: